Who owns Inmune Bio Ord?
- Ticker: INMB
- CUSIP Number: 45782t105
Tip: Access positions for across all investors
Analyze quarterly positions in Inmune Bio Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmune Bio Ord stock
Who bought or sold Inmune Bio Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 541k | $6.4M | 0% | Mar 2024 |
|
| BlackRock | 240k | $2.8M | 3% | Mar 2024 |
|
| MAI Wealth Advisors | 181k | $2.1M | 85% | Mar 2024 |
|
| Rhenman & Partners Asset Management AB | 178k | $2.1M | 0% | Mar 2024 |
|
| Susquehanna International | 178k | $2.1M | 108% | Mar 2024 |
|
| Geode Capital Management | 171k | $2.0M | 2% | Mar 2024 |
|
| Millennium Management | 159k | $1.9M | 558% | Mar 2024 |
|
| Janney Montgomery Scott | 141k | $1.7M | -14% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 110k | $1.3M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 88k | $1.0M | 100% | Mar 2024 |
|
| Royal Bank of Canada | 83k | $974k | 43% | Mar 2024 |
|
| Jane Street | 74k | $869k | 71% | Mar 2024 |
|
| Citigroup | 48k | $565k | 34% | Mar 2024 |
|
| Qube Research & Technologies | 44k | $519k | 100% | Mar 2024 |
|
| Man Group | 41k | $477k | 159% | Mar 2024 |
|
| UBS Group | 38k | $450k | -11% | Mar 2024 |
|
| Westside Investment Management | 34k | $404k | -18% | Mar 2024 |
|
| Laird Norton Tyee Trust | 32k | $370k | 100% | Mar 2024 |
|
| Fermata Advisors | 32k | $370k | 7% | Mar 2024 |
|
| Hrt Financial | 30k | $351k | 100% | Mar 2024 |
|
| Morgan Stanley | 28k | $323k | 573% | Mar 2024 |
|
| Marshall Wace | 27k | $315k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 26k | $307k | -22% | Mar 2024 |
|
| Citadel Advisors | 25k | $293k | -44% | Mar 2024 |
|
| Northern Trust | 20k | $240k | 1% | Mar 2024 |
|
| Balyasny Asset Management | 20k | $236k | -14% | Mar 2024 |
|
| Rockefeller Capital Management | 18k | $205k | 100% | Dec 2023 |
|
| Brevan Howard Capital Management | 16k | $193k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 15k | $170k | 100% | Mar 2024 |
|
| Squarepoint Ops | 13k | $158k | 100% | Mar 2024 |
|
| Point72 Asia | 13k | $158k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 12k | $144k | 15% | Mar 2024 |
|
| Y-Intercept | 11k | $130k | 100% | Mar 2024 |
|
| Laurion Capital Management | 11k | $129k | 0% | Mar 2024 |
|
| Financial Advocates Investment Management | 11k | $123k | -16% | Mar 2024 |
|
| Goss Wealth Management | 11k | $123k | 93% | Mar 2024 |
|
| Beacon Pointe Advisors | 10k | $117k | 0% | Dec 2023 |
|
| LPL Financial | 10k | $118k | -1% | Mar 2024 |
|
| Bank of America Corporation | 8.8k | $103k | -38% | Mar 2024 |
|
| Cubist Systematic Strategies | 4.8k | $56k | 100% | Mar 2024 |
|
| Tower Research Capital | 2.3k | $27k | -11% | Mar 2024 |
|
| Valley National Advisers | 1.0k | $11k | 0% | Mar 2024 |
|
| Continuum Advisory | 1.0k | $11k | 100% | Mar 2024 |
|
| FMR | 585.00 | $6.9k | 588% | Mar 2024 |
|
| Hartland & Co | 420.00 | $4.7k | 0% | Dec 2023 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $4.7k | 100% | Mar 2024 |
|
| Nbc Securities | 270.00 | $3.0k | 0% | Mar 2024 |
|
| IFP Advisors | 184.00 | $2.1k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 147.00 | $1.7k | 1% | Mar 2024 |
|
| FNY Investment Advisers | 100.00 | $1.0k | 0% | Mar 2024 |
|
Who sold out of Inmune Bio Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Quadrant Capital | Dec 2023 | 60k | $676k |
| Group One Trading | Sep 2023 | 46k | $315k |
| 683 Capital Management | Dec 2023 | 19k | $217k |
| Northwestern Mutual Wealth Management Company | Sep 2023 | 4.3k | $29k |
| Jpmorgan Chase & Co | Dec 2023 | 3.5k | $39k |
| Simplex Trading | Dec 2023 | 2.1k | $23k |